Clenbuterol (Spiropent) Research in New York | QSC
QSC RESEARCH GRADE — NEW YORK
≥99% HPLCJanoshik COADomestic USA Shipping
Clenbuterol (Spiropent) Research — New York
Clenbuterol (Spiropent) is a Beta-2 adrenergic receptor (β₂AR) agonist researched for Lipolysis / Fat Loss Research, Skeletal Muscle Anabolism / Anti-Atrophy, Bronchodilation / Respiratory Research. QSC supplies Clenbuterol to researchers across New York with domestic USA shipping and Janoshik COA verification.
Clenbuterol is a long-acting, selective β₂ adrenergic receptor agonist. β₂AR activation triggers adenylyl cyclase → elevated cAMP → protein kinase A (PKA) activation. In bronchial smooth muscle: bronchodilation. In adipose tissue: upregulates hormone-sensitive lipase (HSL) and cAMP-mediated lipolysis. In skeletal muscle: anabolic signalling via cAMP/PKA — pr… Full Clenbuterol Research Hub →
